Dimed: Strong revenue and margin growth, digital gains, and robust cash flow drive expansion

About this update from Dimed S.a. Distribuidora De Medicamentos

Retail revenue grew 18.2% in 4Q25 and 17.0% in 2025, with adjusted EBITDA and net income margins expanding. Digital sales and private label penetration increased, while market share in the South region reached 13.9%. Free cash flow and low leverage support ongoing expansion.Original document: This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

View stock analysis, news, and events for Dimed S.a. Distribuidora De Medicamentos